Satellite needle distribution among injection drug users: Policy and practice in two Canadian cities

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 1, 2002, Pages 98-105

  Tyndall, Mark W ^a   Bruneau, Julie ^a   Brogly, Susan ^a   Spittal, Patricia ^a   O'Shaughnessy, Michael V ^a   Schechter, Martin T ^a  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

Health services; HIV AIDS; Injection drug use; Needle exchange programs

Indexed keywords

ADULT; ARTICLE; CANADA; COMMERCIAL PHENOMENA; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MARKETING; MARRIAGE; NEEDLE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; PURCHASING; RISK MANAGEMENT; VIRUS TRANSMISSION;

EID: 0036740306     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200209010-00013     Document Type: Article

References (26)

1. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:400-6.
2. Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health 2000;77:369-82.
3. Hagan H, Jarlais DC, Friedman SR, et al. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health 1995;85:1531-7.
4. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?. Am J Public Health 1994;84:1991-4.
5. Ljungberg B, Christensson B, Tunving K, et al. HIV prevention among injecting drug users: three years of experience from a syringe exchange program in Sweden. J Acquir Immune Defic Syndr Hum Retrovirol 1991;4:890-5.
6. Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997;349:1797-800.
7. MacDonald MA, Wodak AD, Dolan KA, et al. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Med J Aust 2000;172:57-61.
8. Information on needle exchange programs in Vancouver. Vancouver: Community Services, Social Planning, City of Vancouver, report no. 4113, 1998.
9. Lurie P. When science and politics collide: the federal response to needle-exchange programs. Bull NY Acad Med 1995;72:380-96.
10. Singer M. Needle exchange and AIDS prevention: controversies, policies and research. Med Anthropol 1997;18:1-12.
11. Vlahov D. The role of epidemiology in needle exchange programs. Am J Public Health 2000;90:1390-2.
12. Marmor M, Shore RE, Titus S, et al. Temporal trends in individuals' drug injection rates and histories of needle exchange program utilization. Presented at the National HIV Prevention Conference, 1999:704.
13. Hagan H, McGough JP, Thiede H, et al. Volunteer bias in non-randomized evaluations of the efficacy of needle-exchange programs. J Urban Health 2000;77:103-12.
14. Strathdee SA, Celentano DD, Shah N, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. J Urban Health 1999;76:448-60.
15. Hagan H, McGough JP, Thiede H, et al. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat 2000;19:247-52.
16. Sears C, Guydish JR, Weltzien EK, et al. Investigation of a seeondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. J Acquir Immune Defic Syndr 2001;27:193-201.
17. Valente TW, Foreman RK, Junge B, et al. Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. J Urban Health 2001;78:340-9.
18. Rockwell R, Des Jarlais DC, Friedman SR, et al. Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care 1999;11:437-42.
19. Riley ED, Safaeian M, Strathdee SA, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr 2000;24:57-61.
20. Latkin CA, Forman VL. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr 2001;27:398-404.
21. Coffin P. Syringe availability as HIV prevention: a review of modalities. J Urban Health 2000;77:306-30.
22. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS 1997;8:437-45.
23. Van Ameijden EJ, Langendam MW, Notenboom J, et al. Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. Addiction 1999;94:1051-61.
24. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993;88:517-26.
25. Tyndall M, Johnston C, Craib K, et al. HIV incidence and mortality among injection drug uses in Vancouver-1996-2000. Can J Infect Dis 2001;12(Suppl B):69B.
26. Bruneau J, Lamothe F, Lachance N, et al. Injection behaviours in HIV seroconversion among intravenous drug users in Montreal [abstract 23221]. Int Conf AIDS 1998;12:385-6.